Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biodesix Inc (BDSX)

Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biodesix Inc 919 WEST DILLON RD. LOUISVILLE CO 80027 USA

www.biodesix.com Employees: 273 P: 303-417-0500 F: 866-432-3338

Sector:

Medical

Description:

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 54,258
Enterprise Value, $K 64,438
Shares Outstanding, K 7,956
Annual Sales, $ 71,320 K
Annual Net Income, $ -42,930 K
Last Quarter Sales, $ 21,770 K
Last Quarter Net Income, $ -8,720 K
EBIT, $ -32,340 K
EBITDA, $ -24,180 K
60-Month Beta 0.62
% of Insider Shareholders 30.10%
% of Institutional Shareholders 20.96%
Float, K 5,561
% Float 69.90%
Short Interest 75
Short Float 0.95%
Short Volume Ratio 0.17

Growth:

1-Year Return -76.64%
3-Year Return -85.17%
5-Year Return -98.31%
5-Year Revenue Growth 190.51%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.16 on 11/03/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -5.56
EPS Growth vs. Prev Qtr 27.50%
EPS Growth vs. Prev Year 17.14%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 09/15/25

BDSX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -504.41%
Return-on-Assets % -43.94%
Profit Margin % -60.19%
Debt/Equity -27.40
Price/Sales 0.75
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.22
Interest Coverage -4.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar